VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 403 filers reported holding VANECK VECTORS ETF TR in Q3 2018. The put-call ratio across all filers is 1.55 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,735,696 | +130.6% | 64,500 | +158.0% | 0.01% | +40.0% |
| Q2 2023 | $752,750 | +5.1% | 25,000 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $716,500 | -40.6% | 25,000 | -50.0% | 0.01% | -36.4% |
| Q3 2022 | $1,206,000 | +46.9% | 50,000 | +66.7% | 0.01% | +83.3% |
| Q2 2022 | $821,000 | -27.6% | 30,000 | -44.2% | 0.01% | -60.0% |
| Q4 2018 | $1,134,000 | -42.1% | 53,750 | -49.2% | 0.02% | -37.5% |
| Q3 2018 | $1,958,000 | +10.5% | 105,750 | +36.1% | 0.02% | 0.0% |
| Q1 2017 | $1,772,000 | +34.4% | 77,680 | +23.3% | 0.02% | +71.4% |
| Q4 2016 | $1,318,000 | +30.4% | 63,000 | +72.6% | 0.01% | -54.8% |
| Q2 2016 | $1,011,000 | – | 36,510 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
| Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
| New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
| New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
| MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
| Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
| Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
| Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
| Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
| Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |